<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="461">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05155150</url>
  </required_header>
  <id_info>
    <org_study_id>112002</org_study_id>
    <nct_id>NCT05155150</nct_id>
  </id_info>
  <brief_title>Improving Shared-Decision Making in the Intensive Care Unit Using Patient-reported Outcome Information</brief_title>
  <official_title>Improving Shared-Decision Making in the Intensive Care Unit Using Patient-reported Outcome Information</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jeroen Bosch Ziekenhuis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effect of incorporation of outcome information in&#xD;
      the Intensive Care Unit (ICU) decision-making process on patient and family reported outcomes&#xD;
      and experiences of patients, relatives and ICU clinicians in a randomized clinical trial&#xD;
      design in the Jeroen Bosch Ziekenhuis and Radboudumc in the Netherlands.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background Due to advances in critical care medicine, more patients survive their critical&#xD;
      illness. However, many Intensive Care Unit (ICU) survivors suffer from physical, cognitive&#xD;
      and/or mental problems impacting patients' quality of life (QoL). Because of a lack of&#xD;
      long-term outcome information, ICU physicians make decisions regarding ICU treatment based on&#xD;
      their clinical experience and intuition. Moreover, patients and relatives are often not&#xD;
      involved in the decision-making process.&#xD;
&#xD;
      To improve the ICU decision-making process and to make it more substantiated, the use of&#xD;
      patient-reported outcome measures (PROMs) is of utmost importance. Therefore, the Radboudumc,&#xD;
      in collaboration with six regional hospitals, including Jeroen Bosch Ziekenhuis (JBZ), set up&#xD;
      a large-scale prospective cohort study, MONITOR-IC (www.monitor-ic.nl), to study long-term&#xD;
      outcomes of ICU survivors', their QoL and their needs.&#xD;
&#xD;
      This research sets out to evaluate the effect of incorporation of outcome information in the&#xD;
      ICU decision-making process on patient and family reported outcomes and experiences of&#xD;
      patients, relatives and ICU clinicians in a randomized clinical trial design in the Jeroen&#xD;
      Bosch Ziekenhuis and Radboudumc in the Netherlands.&#xD;
&#xD;
      Methods A prediction model for long-term QoL was previously developed using physiological,&#xD;
      pathological, drug and treatment data from patients' electronic health record combined with&#xD;
      PROMs from one centre of the MONITOR-IC. It was externally validated with the data of six&#xD;
      other centres and an E-health tool was developed, incorporating this prediction model. For&#xD;
      this research, the E-health tool will be incorporated in family meetings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 9, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized trial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient reported experience measure (PREM)</measure>
    <time_frame>Within 3 months of family meeting</time_frame>
    <description>Patient and/or relative's experience (measured using the CollaboRATE)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcome measure (PROM)</measure>
    <time_frame>After 3 months and after 1 year</time_frame>
    <description>Quality of life (measured using the EuroQol five-dimensional questionnaire [EQ-5D-5L])</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU professionals' experiences</measure>
    <time_frame>Two months before inclusion first patient and two months after inclusion last patient</time_frame>
    <description>Measured using the Ethical Decision-Making Climate Questionnaire (EDMCQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcome measure (PROM)</measure>
    <time_frame>After 3 months and after 1 year</time_frame>
    <description>Anxiety and depression (measured using the Hospital Anxiety and Depression Scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Intensive Care Unit Syndrome</condition>
  <condition>Patient Engagement</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Providing patient-reported outcome: patients receive personalized information on expected quality of life one year after ICU during ICU admission (during a family meeting)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Family meetings take place as usual.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Providing patient-reported outcome</intervention_name>
    <description>Patients receive personalized information on expected quality of life one year after ICU during ICU admission (during a family meeting)</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted to the ICU for 12 hours or more&#xD;
&#xD;
          -  Patients (or their legal representative) provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients admitted to the ICU due to a COVID-19 infection&#xD;
&#xD;
          -  Moribund patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marieke Zegers, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intensive Care, Radboud university medical center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Koen Simons, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intensive Care, Jeroen Bosch Ziekenhuis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Van den Boogaard, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intensive Care, Radboud university medical center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marieke Zegers, PhD</last_name>
    <phone>0031243619269</phone>
    <email>Marieke.Zegers@radboudumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mark van den Boogaard, PhD</last_name>
    <email>Mark.vandenBoogaard@radboudumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Radboud university medical centre</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6525GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marieke Zegers, PhD</last_name>
      <phone>0031243619269</phone>
      <email>Marieke.Zegers@radboudumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Mark van den Boogaard, PhD</last_name>
      <email>Mark.vandenBoogaard@radboudumc.nl</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Jeroen Bosch Ziekenhuis</name>
      <address>
        <city>'s-Hertogenbosch</city>
        <state>Noord-Brabant</state>
        <zip>5223GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koen Simons, MD, PhD</last_name>
      <email>k.simons@jbz.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 17, 2021</study_first_submitted>
  <study_first_submitted_qc>November 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2021</study_first_posted>
  <last_update_submitted>November 29, 2021</last_update_submitted>
  <last_update_submitted_qc>November 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Radboud University</investigator_affiliation>
    <investigator_full_name>Marieke Zegers</investigator_full_name>
    <investigator_title>PhD and Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Share decision making</keyword>
  <keyword>Intensive Care Unit</keyword>
  <keyword>Quality of life</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

